Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma
- 31 October 2006
- journal article
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 17 (6), 412-416
- https://doi.org/10.1016/j.ejim.2006.02.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cellsImmunology Letters, 2005
- Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromesLeukemia Research, 2005
- The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical reviewBritish Journal of Haematology, 2005
- Interleukin-17 augments tumor necrosis factor-α-induced elaboration of proangiogenic factors from fibroblastsImmunology Letters, 2004
- Bone marrow microvascular density and angiogenic growth factors in multiple myelomacclm, 2004
- A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myelomaThrombosis and Haemostasis, 2004
- A review of the cytokine network in multiple myelomaCancer, 2003
- Interleukin-17 promotes angiogenesis and tumor growthBlood, 2002
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal Of Cancer, 2002
- Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules?The Journal of Experimental Medicine, 1996